These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1096 related articles for article (PubMed ID: 25652908)

  • 21. Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening.
    Cuzick J; Adcock R; Carozzi F; Gillio-Tos A; De Marco L; Del Mistro A; Frayle H; Girlando S; Sani C; Confortini M; Zorzi M; Giorgi-Rossi P; Rizzolo R; Ronco G;
    Int J Cancer; 2020 Oct; 147(7):1864-1873. PubMed ID: 32170961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions.
    Sørbye SW; Fismen S; Gutteberg TJ; Mortensen ES; Skjeldestad FE
    PLoS One; 2014; 9(11):e112934. PubMed ID: 25405981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triage of ASC-H: A meta-analysis of the accuracy of high-risk HPV testing and other markers to detect cervical precancer.
    Xu L; Verdoodt F; Wentzensen N; Bergeron C; Arbyn M
    Cancer Cytopathol; 2016 Apr; 124(4):261-72. PubMed ID: 26618614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the diagnostic value of cervical cytology and HPV HR DNA testing for the diagnosis of low-grade and high-grade squamous intraepithelial lesions across different age groups.
    Paluszkiewicz A; Pruski D; Iwaniec K; Kędzia W
    Ginekol Pol; 2017; 88(3):141-146. PubMed ID: 28397203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pooled analysis on the necessity of random 4-quadrant cervical biopsies and endocervical curettage in women with positive screening but negative colposcopy.
    Hu SY; Zhang WH; Li SM; Li N; Huang MN; Pan QJ; Zhang X; Han Y; Zhao FH; Chen W; Qiao YL
    Medicine (Baltimore); 2017 Apr; 96(17):e6689. PubMed ID: 28445270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results.
    Schiffman M; Vaughan LM; Raine-Bennett TR; Castle PE; Katki HA; Gage JC; Fetterman B; Befano B; Wentzensen N
    Gynecol Oncol; 2015 Sep; 138(3):573-8. PubMed ID: 26148763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of optical coherence tomography in the triage of women with minor abnormal cervical cytology before colposcopy.
    Yan L; Xiao X; He L; Shi L; Yang X; Zhang J; Zhang Y; Fu C
    PLoS One; 2023; 18(3):e0282833. PubMed ID: 36913396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of Triage for Atypical Squamous Cells of Undetermined Significance with Human Papillomavirus Testing in Cervical Cancer Screening in Japan.
    Fujiwara H; Suzuki M; Morisawa H; Sayama M; Kimura K
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):81-85. PubMed ID: 30678384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
    Cox JT;
    Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.
    Castle PE; Fetterman B; Thomas Cox J; Shaber R; Poitras N; Lorey T; Kinney W
    Obstet Gynecol; 2010 Jul; 116(1):76-84. PubMed ID: 20567171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining the Longitudinal Risk of CIN 3+ for Piedimonte S; Tsang K; Jembere N; Murphy J; Karapetian T; Gao J; McCurdy B; Sacco J; Kupets R
    J Low Genit Tract Dis; 2024 Jan; 28(1):7-11. PubMed ID: 37906611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia.
    Simms KT; Hall M; Smith MA; Lew JB; Hughes S; Yuill S; Hammond I; Saville M; Canfell K
    PLoS One; 2017; 12(1):e0163509. PubMed ID: 28095411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of Human Papillomavirus Genotyping for Triage of Patients with Atypical Squamous Cells of Undetermined Significance by Cervical Cytology.
    Lee B; Suh DH; Kim K; No JH; Kim YB
    Anticancer Res; 2015 Jul; 35(7):4197-202. PubMed ID: 26124378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16
    Song F; Yan P; Huang X; Wang C; Qu X; Du H; Wu R
    BMC Infect Dis; 2021 Apr; 21(1):400. PubMed ID: 33931022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical Cancer Screening: A Review.
    Perkins RB; Wentzensen N; Guido RS; Schiffman M
    JAMA; 2023 Aug; 330(6):547-558. PubMed ID: 37552298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Intaraphet S; Siriaunkgul S
    J Med Virol; 2016 Jan; 88(1):135-43. PubMed ID: 26129775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
    Castle PE; Reid J; Dockter J; Getman D
    J Clin Virol; 2015 Aug; 69():52-5. PubMed ID: 26209379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
    Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
    Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.